Ascorbic Acid to Manage Psychiatric Disorders (Q39363527)

11 September 2017

1 reference

title

Ascorbic Acid to Manage Psychiatric Disorders (English)

1 reference

11 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28600627 AND SRC:MED&resulttype=core&format=json

31 May 2020

Ana Lúcia S Rodrigues

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28600627 AND SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Daiane Bittencourt Fraga

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28600627 AND SRC:MED&resulttype=core&format=json

31 May 2020

publication date

9 June 2017

1 reference

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28600627 AND SRC:MED&resulttype=core&format=json

31 May 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28600627 AND SRC:MED&resulttype=core&format=json

31 May 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28600627 AND SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

571-583

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28600627 AND SRC:MED&resulttype=core&format=json

A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Ascorbate regulation and its neuroprotective role in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Vitamin C in human health and disease is still a mystery? An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Vitamin C as an antioxidant: evaluation of its role in disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Strategies of antioxidant defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Oxidative stress, glutamate, and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Oxidative stress and epilepsy: literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Mechanism of oxidative stress in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Protein oxidation in Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Ascorbic acid: an endogenous inhibitor of isolated Na ,K -ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Some behavioural and EEG effects of ascorbic acid in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Effect of drug-induced ascorbic acid release in the striatum and the nucleus accumbens in hippocampus-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Schizophrenia: from dopaminergic to glutamatergic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Glutamatergic agents for schizophrenia: current evidence and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Intrastriatal infusions of ascorbate antagonize the behavioral response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Ascorbic acid could be hazardous to your experiments: A commentary on dopamine receptor binding studies with speculation on a role for ascorbic acid in neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Modulation of neostriatal activity by iontophoresis of ascorbic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

The effect of unilateral cortical lesions on the circadian changes in rat striatal ascorbate and homovanillic acid levels measured in vivo using voltammetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

The effects of cortical ablation on d-amphetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Implications for reactive oxygen species in schizophrenia pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Oxidative injury and antioxidant vitamins E and C in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Effects of antipsychotics and vitamin C on the formation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E C in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

New approaches to antidepressant drug discovery: beyond monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

TNF-α-induced depressive-like phenotype and p38(MAPK) activation are abolished by ascorbic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Regulation of embryonic neurotransmitter and tyrosine hydroxylase protein levels by ascorbic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Signaling pathways underlying the rapid antidepressant actions of ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Poor vitamin C status is associated with increased depression symptoms following acute illness in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Fruit, vegetable, and antioxidant intakes are lower in older adults with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Total antioxidant capacity of diet and serum, dietary antioxidant vitamins intake, and serum hs-CRP levels in relation to depression scales in university male students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: a randomized, single-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Vitamin C as an adjuvant for treating major depressive disorder and suicidal behavior, a randomized placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Staging Models in Bipolar Disorder: A Systematic Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Targeting astrocytes in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Review of nutritional supplements for the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Intracerebroventricular administration of ouabain as a model of mania in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

The wnt pathway in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

High fluence low‐power laser irradiation induces apoptosis via inactivation of Akt/GSK3β signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Redox reactions of the α-synuclein-Cu(2 ) complex and their effects on neuronal cell viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington's disease in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

Ascorbic acid ameliorates behavioural deficits and neuropathological alterations in rat model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0446-8

The origin of circadian and amphetamine-induced changes in the extracellular concentration of brain ascorbate

21 January 2018

1 reference

12 December 2020

Involvement of different types of potassium channels in the antidepressant-like effect of ascorbic acid in the mouse tail suspension test

1 reference

12 December 2020

Criteria and recommendations for vitamin C intake

1 reference

12 December 2020

Plasma levels and urinary vitamin C excretion in schizophrenic patients

1 reference

12 December 2020

Scurvy and psychiatric symptoms.

1 reference

12 December 2020

Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Scurvy in a patient with depression

1 reference

12 December 2020

An adjunctive role for ascorbic acid in the treatment of schizophrenia?

1 reference

12 December 2020

Differential effects of drug-induced ascorbic acid release in the striatum and nucleus accumbens of freely moving rats

1 reference

12 December 2020

Does the dopamine hypothesis explain schizophrenia?

1 reference

12 December 2020

Ascorbic acid reduces accumulation of [3H]spiperone in mouse striatum in vivo

1 reference

12 December 2020

Nutrition and depressive symptoms in community-dwelling elderly persons in Japan

1 reference

12 December 2020

Augmentation of haloperidol by ascorbic acid in phencyclidine intoxication

1 reference

12 December 2020

Ascorbic acid and catecholamine secretion from cultured chromaffin cells

1 reference

12 December 2020

The effect of high ascorbic acid supplementation on body iron stores

1 reference

12 December 2020

Schwann cell myelination in a chemically defined medium: demonstration of a requirement for additives that promote Schwann cell extracellular matrix formation

1 reference

12 December 2020

Vitamin C in the treatment of schizophrenia

1 reference

12 December 2020

The therapeutic effect of ascorbic acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard treatments

1 reference

12 December 2020

Effect of ascorbic acid on neurochemical, behavioral, and physiological systems mediated by catecholamines

1 reference

12 December 2020

Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats

1 reference

12 December 2020

Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids

1 reference

12 December 2020

Differential inhibitory effects of ascorbic acid on the binding of dopamine agonists and antagonists to neostriatal membrane preparations: correlations with behavioral effects

1 reference

12 December 2020

Ascorbic acid, an endogenous factor required for acetylcholine release from the synaptic vesicles

1 reference

12 December 2020

Ascorbic acid inhibition of Na,K-adenosine triphosphatase of rat forebrain without peroxidation of membrane lipids

1 reference

12 December 2020

Ascorbic acid in the brain

1 reference

12 December 2020

Vanadium: a possible aetiological factor in manic depressive illness

1 reference

12 December 2020

Antidepressant effect of vitamin C

1 reference

12 December 2020

Ascorbic acid in the brain

1 reference

12 December 2020

Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum

1 reference

12 December 2020

10.1007/S40263-017-0446-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28600627 AND SRC:MED&resulttype=core&format=json

31 May 2020

1 reference